Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2

This study has been completed.

Study NCT00034281 Information provided by Takeda Global Research & Development Center, Inc.

First Received: April 24, 2002 Last Updated: December 18, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2003
Primary Completion Date:	September 2003 (Final data collection date for primary outcome measure)